By proceeding, you agree to our Terms of Use and Privacy Policy.
Zheng Feng Director; Global Clinical Biomarkers & Companion Diagnostics; Global Development at EMD Serono, Inc.
Talks About #Biomarkers
Preferred Locations #NorthAmerica
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift.